Asia Business News | Saturday, July 05, 2008
RSS 2.0  
PanBio Limited (ASX: PBO) develops, commercialises and markets a range of medical diagnostic kits used by hospitals, pathology laboratories, general practitioners and research institutions to test for infectious diseases. PBO has more than 60 diagnostic tests for more than 27 infectious diseases including Dengue fever, Ross River fever, glandular fever and whooping cough. As at 30 June 2004, the company supported over 120 clinical laboratories in Australia, Asia, the Americas, Europe, the Middle East and Africa.
Company Headquarters 532 Seventeen Mile Rocks Road Sinnamon Park, QLD 4073 
Company Telephone (07) 3363 7100 
Company Fax 07 3363 7199 
Company Principal Sector Health & Pharm 
Company Principal Industry Biotechnology 
Company Listed 2001/04/09 
Company Homepage www.panbio.com.au
 
Stock Exchange Stock Code
  ASX:PBOPBO
ZOBEXPBJ
EUREXPBJ
XETRAPBJ
 PINK:PNBOFPNBOF
News Reader RSS   PANBIO LIMITED
 Aust Market Outlook, (ASX: SYB), (ASX: BHP), (ASX: PBO), (ASX: HSP) (OCT 9, 2007)
Drag Podcast Icon To iTunes - Podcast Download for PANBIO LIMITED
 PANBIO LIMITED ASX: PBO - Market Update - Mr Paul Nitz, CEO/MD (MAY 2, 2006)